BRD-K33379087-001-07-5
HELA
maintaining cell culture
LINCS-2021
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.B003 HELA 24H H14 tivantinib 0.74uM.tsv.gz
uterine cervix
Label
Description
A Substance
A 180 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project